Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).
Report type:
Report
Status: Commission completed
Department/Division:
Drug Assessment
Application field:
Head and nerves
10.09.2009
Alzheimer’s disease: only a few therapies provide proof of benefit to patients
Cholinesterase inhibitors and ginkgo may alleviate some symptoms – Non-drug approaches are insufficiently investigated – Marked increase in supporting...
Ginkgo biloba in Alzheimer's disease: evidence from studies is mixed
With high-dose Ginkgo, patients cope better with daily activities / Studies from Eastern Europe showing particularly positive effects dominate the assessment
Accompanying information